 |
 |

Unilateral Surgery for Primary Hyperparathyroidism on the Basis of Technetium Tc 99m Sestamibi and Iodine 123 Subtraction Scanning
Elif Hindié, MD, PhD;
Didier Mellière, MD;
Christian Jeanguillaume, MD;
Pablo Ureña, MD;
Claire deLabriolle-Vaylet, MD;
Léon Perlemuter, MD
Arch Surg. 2000;135:1461-1468.
Hypothesis Parathyroid scanning, based on simultaneous recording of technetium Tc 99m sestamibi and iodine 123 images, is able to identify patients with multiple parathyroid gland disease and is a safe imaging technique for unilateral parathyroid surgery.
Design Scintigraphic criteria of eligibility for unilateral surgery were prospectively tested against findings of conventional bilateral surgery.
Setting Patients referred to an endocrine surgeon in a university hospital.
Patients Seventy consecutive patients with primary hyperparathyroidism had dual-isotope scanning before conventional surgery. Forty-one patients had scan findings compatible with unilateral surgery, with a single focus of high intensity seen on the anterior and lateral views. The remaining 29 patients had 1 or more criteria of ineligibility: (1) scan findings pointing to multiple gland disease, (2) no well-identified focus, (3) contralateral thyroid nodule requiring surgical management, or (4) family history of hyperparathyroidism or multiple endocrine disease.
Main Outcome Measures Number of enlarged parathyroid glands at surgical inspection and calcemia follow-up.
Results None of the 41 patients, with a single well-defined focus on the scan image, showed evidence of multiple parathyroid involvement. Each parathyroid adenoma was resected from the precise site predicted by the subtraction scan. Nine patients (13%) had surgical findings of multiple parathyroid gland disease. All 9 were ineligible based on preoperative image findings.
Conclusions Unilateral surgery can be safely offered to 60% of patients with primary hyperparathyroidism, on the basis of simultaneous 99mTc-sestamibi and 123I scanning. This may reduce the length of the operation, anesthesia requirements, and hospital stay, and the risks of hypoparathyroidism and injury to the recurrent laryngeal nerve.
From the Department of Nuclear Medicine, Hôpital St-Antoine, Assistance Publique-Hôpitaux de Paris, Paris (Drs Hindié and deLabriolle-Vaylet); the Departments of Endocrine Surgery (Dr Mellière), Nuclear Medicine (Dr Jeanguillaume), and Endocrinology (Dr Perlemuter), Hôpital Henri Mondor, Créteil; and the Nephrology Unit, Clinique de l'Orangerie, Aubervilliers (Dr Ureña), France.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(12):1479-1480.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Technetium tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
Bleier et al.
Arch Otolaryngol Head Neck Surg 2006;132:779-782.
ABSTRACT
| FULL TEXT
Multiple-Gland Disease in Primary Hyperparathyroidism: A Function of Operative Approach?
Lee and Norton
Arch Surg 2002;137:896-900.
ABSTRACT
| FULL TEXT
|